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Abstract
Background: Reviews of randomized controlled trials (RCTs) of cognitive behavioural therapy (CBT) for anxiety
disorders have reported large pre- to post-treatment within-group effect sizes on measures of anxiety when
supplied in therapist consultations and in technology-supported settings. However, the stringent experimental
control of RCTs results in a lack of external validity, which limits the generalizability of findings to real-world
frontline clinical practice. We set out to examine the specification of a protocol for study of the effectiveness of cell
phone-supported CBT for in situ management of anxiety disorders.
Methods and design: Nominal group methods were used for requirements analysis and protocol design. Making
a distinction between different forms of technology-supported therapy, examination of therapists’ role, and
implementing trials in existing organizational and community contexts were found to be the central requirements
in the protocol.
Discussion: The resulting protocol (NCT01205191 at clinicaltrials.gov) for use in frontline clinical practice in which
effectiveness, adherence, and the role of the therapists are analyzed, provides evidence for what are truly valuable
cell phone-supported CBT treatments and guidance for the broader introduction of CBT in health services.
Background
Ample evidence indicates that anxiety is under treated
in western societies, and that large numbers of the
population suffer needlessly. The World Health Organi-
zation (WHO) has estimated that 40% of disability
attributed to anxiety reflects the fact that many potential
anxiety patients never reach health care [1]. A major
factor contributing to this shortcoming is that evidence-
based psychotherapies are not practiced widely in com-
munity settings [2,3]. For instance, less than a quarter of
those with anxiety disorders in the United Kingdom
receive treatment of any sort [4]. In the United States,
only about 40% of patients with mood or anxiety disor-
ders receive any treatment [5]. It is in this context that
expectations of cognitive behavioural therapy (CBT) are
high. CBT methodology has the advantage of using
well-defined treatment practices that can be easily
taught to a variety of therapists and whose implementa-
tion can be monitored. Reviews of randomized con-
t r o l l e dt r i a l s( R C T s )o fC B Tfor anxiety disorders have
reported large pre- to post-treatment within-group
effect sizes on measures of anxiety when supplied in
therapist consultations [6,7], in computer-supported ses-
sions at practices [8,9], and over the Internet [10,11]. In
Sweden, CBT is the current treatment of choice for
mild to moderate anxiety disorder [12].
Despite its proven efficacy, CBT still seems to be
neglected in practice settings. In this study, we address
2 possible reasons for this situation. The first is that
most of the research has been conducted using samples
with isolated (rather than comorbid) disorders, but most
therapists help individuals with multiple comorbid pro-
blems. It is not known if CBT techniques adapted to a
particular client’s needs by a skilled therapist in a com-
munity setting achieve a better result than a therapist
following a structured routine. It does seem that experi-
enced therapists prefer to select from a variety of tech-
niques rather than to follow a regimented program.
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complex phenomenon in frontline CBT practice [13].
The refractory nature of this problem is reflected by the
fact that a large proportion of non-adherence has come
to be routinely accepted when planning interventions.
Critics argue that RCTs’ stringent experimental controls
(e.g. patients with homogenous diagnoses and highly
trained and supervised therapists) result in a lack of
external validity, which limits the generalizability of
findings to real-world or frontline clinical practice
[14,15]. In addition, studies of the effectiveness of CBT
for anxiety disorders have consistently reported lower
patient adherence than RCTs [13,16].
The second possible reason for under utilization is
that a fundamental principle in CBT is to document and
adjust behaviour and thought processes when and where
they occur. Accordingly, a goal in developing novel
applications of CBT should be to assist therapy in situ,
that is, exactly when it is needed. Using participatory
design methods, we have developed a set of such appli-
cations [17]. In this process, we acknowledge that adher-
ence to mental health services is no longer only a matter
of complying with a decided course of treatment in a
clinical setting, but of reaching, connecting to, motivat-
ing, and sharing health decisions with patients and
populations (Figure 1). The perspective on health service
provision thereby shifts from biomedicine to infomedi-
cine; patients and health workers join in informed,
shared decision-making and governance [18].
We conclude that there is a need to examine carefully
the external validity and effectiveness of CBT treatments
for anxiety that have already been shown to be effica-
cious, and to identify factors that reduce non-adherence.
In this study, we used these presumptions to plan for
the examination of a new generation of CBT programs.
With this understanding, we set out to define a protocol
for examination of the effectiveness of cell phone-
supported CBT for anxiety disorders in frontline settings
that also allows to evaluate adherence to therapy. Speci-
fically, the aims of this study were to define a protocol
for assessment of
￿ the superiority of cell phone-supported CBT (CBT-
cell phone) treatment against anxiety disorders com-
pared with CBT treatment as usual (CBT-TAU), and
￿ adherence with CBT-cell phone compared with
CBT-TAU and CBT provided with access to a pla-
cebo technical device (CBT-placebo).
Methods and design
Nominal group methods [19] were used for require-
ments analysis and protocol design (Figure 2). Two
expert panels examined requirements on the data to be
collected: a technical design panel (n = 5) with a back-
ground in computer science and cognitive science, and
a therapy panel (n = 4) consisting of practising thera-
pists. The requirements data collected were transferred
to a study protocol design panel (n =6 )w i t hab a c k -
ground in social medicine, general practice, CBT prac-
tice, health informatics, and cognitive science.
Requirements data collection
The task communicated to the therapy panel was to
make sure the protocol conformed to organizational and
therapeutic routines and content. The task communi-
cated to the technical design panel was to make sure
that the protocol conformed to present cell phone tech-
nology and limitations. In addition, the technical design
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Unaware Unwilling to commit
Lack of persistence
Individuals completed the
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Figure 1 Health service perspective on non-adherence to CBT for anxiety disorders.
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a specification of the technical systems to ensure that,
in accordance with the protocol, the content of the
technical solution was compatible with the paper-based
homework used in present CBT for anxiety syndrome.
Requirements data analysis
The data from the study requirement analysis were
transferred to a protocol specification by the study pro-
tocol panel. The specification was developed during a
series of meetings lasting for 2 hours each (n =8 )a t
which the study protocol, technical design, and therapy
methods in use were systematically developed and dis-
cussed. The specification was finally refined at separate
meetings with the therapy and technical design panels.
Study protocol requirements
The results of the requirement analysis yielded 3
requirement areas that were found to be important
when studying the effectiveness and adherence to cell
phone-supported CBT in a community context.
Effectiveness trials
Even if different forms of CBT have been shown to be
efficacious in RCTs, therapy provided in a community
setting entails a wider variety of patient problems and
comorbidity. A recent meta-analytic review of CBT sup-
ported by or delivered through information technology
(IT) found no significant differences between face-to-
face and computer-aided psychotherapy for anxiety and
no differences between the system used (PC, palmtop,
other) [20]. However, many studies of computer-aided
CBT have used small samples. It is also a concern that
most studies of computer support in CBT lack details
on therapist contacts, time spent on assessment and
diagnosis, and sparse reports of interventions delivered
by ordinary therapists [21]. When introducing cell
phone support in therapy in front-line settings, it is
therefore important to be specific regarding what is
compared, and to provide a large enough sample to be
able to determine differences in effectiveness.
The role of the therapist
Another important issue in effectiveness evaluations of
IT-supported therapy is non-adherence. In RCTs of com-
puter-supported CBT, different methods have been used
to deal with dropouts (e.g. including only completers)
[20]. Based on the evidence from the RCTs reported, it is
tempting to meet the growing demand for CBT with
computer-based therapy programs. However, although
effective computer-based treatments have been tailored
for specific and well-diagnosed patients, in practice there
is a substantial comorbidity between anxiety and other
mental illnesses, and the therapists variable in this con-
text is still not well understood [21,22]. Tailoring of
Internet therapies according to diagnostic profiles may
b ep o s s i b l e ;h o w e v e r ,v i s i t o r st ot h e r a p yw e bs i t e sw h o
have registered on their own initiative have also had lar-
ger dropout rates than that reported in RCTs [23].
Organizational and community context
To examine the effectiveness rather than the efficacy of
CBT, it is important to include comorbid disorders and
base the study on total populations. Reviews of RCTs of
CBT for anxiety disorders have reported large pre- to
post-treatment within-group effect sizes on measures of
anxiety when supplied in therapist consultations in com-
puter-supported sessions atp r a c t i c e s[ 8 , 9 ]a n do nt h e
Internet [10,11]. Yet, effective dissemination of evi-
dence-based intervention to community stakeholders
has been shown to be challenging [24]. Facing the diffi-
culties of closing the gap between research and practice,
the UCLA/RAND NIMH Center has developed a frame-
work to assess the relevant contextual factors, identify,
develop and evaluate new strategies, provide useful for-
mative feedback, develop capacity among stakeholders
and to meaningfully generalize findings. Evidence on
dissemination and implementation in an organizational
and community context rests on process evaluation of
contextual factors, stages of diffusion, and outcome of
interventions [24]. A successful outcome in one imple-
mentation is only anecdotal evidence, unless some eva-
luation of the context (structure and process) and
adaptations made for the context are also documented.
Study protocol
The final protocol (NCT01205191 at clinicaltrials.gov)
informed by the data analysis was developed with regard
to the observed limitations of earlier studies of compu-
ter-supported CBT; e.g. the substantial dropout rates,
partial neglect of therapist involvement, and lack of
Technical
design panel
Study protocol
panel
Therapy panel
Conform with
therapy routines
Conform with
therapy content
Limitations
of technical design
Study
protocol
Technical
design
Figure 2 Flow of study protocol specification and development
of requirements during the formulation process.
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supported methods [21]. The protocol is presented as it
is implemented in a study at the Unga Vuxna (Young
Adults) clinic in Östergötland County, Sweden.
Study setting
The Unga Vuxna service accepts clients aged 18-25 years
from a total population in a region in southern Sweden
(n = 20,000) following a therapist telephone triage
(Figure 3). All therapists (clinical psychologists, social
workers) have a two-year (certified) academic training in
CBT. The intervention at Unga Vuxna consists of 6 CBT
sessions, each lasting 45 minutes. Sessions follow a prede-
fined program, but are also customized to the patient’s
specific needs, including initial assessment whether the
patient has expressed any suicidal intent. Clients also con-
tinue to receive pharmacotherapy if previously prescribed
by their physician. A report of the patient’sp r o g r e s s ,
including whether the patient has expressed any suicidal
intent, is recorded. Homework projects are generated for
each patient, to be accomplished before the next session.
A report of the patient’sp r o g r e s si sr e c o r d e da n da l lc l i -
ents are followed up by a visit at the clinic 3 months after
the therapy has been concluded.
Study inclusion criteria
The inclusion criteria are: (1) age 18 to 25 years and (2)
scoring 7 or higher on the anxiety section of the Hospi-
tal Anxiety and Depression Scale (HAD) at initial eva-
luation. Clients are excluded if they: (1) display
symptoms at the initial evaluation that suggest referral
to a psychiatric specialist, e.g. active suicidal ideas or
symptoms of a psychotic disorder, organic mental disor-
der or alcohol and/or drug dependence or (2) are unable
to read, write or speak Swedish.
Study performance
Treatments
Clients receive whatever treatment their therapist pre-
scribes. To replicate natural conditions, interventions
received by clients are not constrained by the study.
The interventions thus also include, for example, provi-
sion of practical/social support at the employment
office, and further medical investigations.
Procedures
The procedure follows the intention to treat (ITT) prin-
ciple, that is, based on the initial treatment intent, not
on the treatment eventually administered. The Unga
Vuxna service accepts clients following a therapist tele-
phone triage. Recruitment to the study is administered
in association with the first CBT session at the clinic. At
this session, routine screening is performed by adminis-
trating the Hospital Anxiety and Depression Scale
(HADS) to clients. Individuals found fitting the study
criteria are presented with information materials about
the study by a study nurse. The materials are made
available to the client for evaluation in private without
the therapist being present. The allocation schedule is
generated by a biostatistician outside the clinic before
the study commences using an individual unit of rando-
mization. Individuals who fit the inclusion criteria and
have consented to participate are stratified according to
whether they are prescribed medication or not (yes, no)
and with regard to their HADS-D score. They are
then randomly allocated to receive CBT-cell phone,
CBT-TAU, or CBT-placebo (Figure 4). To parallel the
IT-lending situation in the CBT-cell phone strand (in
adherence analyses), the clients allocated to CBT-
placebo are provided with an MP3-player with anti-
stress materials to use between the sessions. The sealed
envelopes are opened in strict numerical sequence by
the study nurse. The nurse is instructed to spend no
more than 10 minutes before and after each session
with each client.
Study outcome measures
The primary outcome measure is the Beck Anxiety
Inventory [BAI]. The BAI [25] is a 21-item symptom
checklist rated on a 4-point scale (0-3). The main sec-
ondary set of outcome measures describes patient
adherence. Data on adherence are collected in 4 dimen-
sions from the therapists after the last session; that is
whether the client has
￿ discontinued the CBT program by not showing up
at sessions;
￿ discontinued the CBT program by actively inform-
ing the therapist;
￿ been discontinued from the treatment by the
therapist; and
￿ not fulfilled the therapeutic contract, e.g. by not
completing homework agreed upon.
The remaining secondary outcome measures are
HADS-A and -D, and the General Health Questionnaire
Young adults
age 18-25
Linköping-Kisa-Åtvidaberg
n ≈ 20 000
Contact with ’Unga Vuxna’ during 1 year
n ≈ 500
Substance
abuse
Relational
problems
Other
reasons
Anxiety
syndrome
n ≈ 250
Behavioural
problems
Figure 3 Overview of the population offered the Unga Vuxna
service in Östergötland, Sweden.
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each of 3 occasions: pre-treatment, when the partici-
pants had completed their programme, and with follow-
up at 6 months. The GHQ has demonstrated validity
with young adults (17+ years) from the United Kingdom
[26]. The sensitivity and specificity for both HADS-A
and HADS-D are similar to the sensitivity and specificity
achieved by the GHQ and they perform well in assessing
the symptom severity of anxiety disorders and depres-
sion in both somatic, psychiatric and primary care
patients, and in the general population [27].
Statistical analysis
Power calculations were performed to determine the
minimum sample size needed to fulfil the research aims.
The calculations were based on change scores (pre- to
post-treatment) between groups in 2 previous studies
comparing CBT as usual with CBT supported by
handheld computers [28] and CBT provided by station-
ary surgery-located computers [9]. To detect a standard
deviation difference of 0.3 in BAI change scores at 80%
power and with 0.05 alpha, we determined that a total
sample size close to 150 per stand (450 in total) was
needed.
For each of the outcome measures, a series of mixed
effects models will be considered. Such models are
described in detail by Everitt and Pickles [29]. Model
adjustments will be used to analyse associations between
pre- and post-randomization values of outcome
(i.e. post-CBT and 6 months follow-up), treatment,
drugs, and parallel depression. For dimensional out-
comes (anxiety scores), ITT analyses will be conducted
using all participants enrolled in the study, and the last
available data point will be used as the post-treatment
score. Uncontrolled effect sizes will be calculated for
pre- to post-treatment change. For categorical outcomes
Contact with Unga
Vuxna and HADS >6
n ≈ 24 patients / month
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8
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8
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Figure 4 Study procedures. The average treatment period at Unga Vuxna is 3 months.
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Page 5 of 7(adherence), treatments will be compared using Pear-
son’s chi-square test, Fisher’s exact test, or logistic
regression, as appropriate.
Ethical considerations
The study protocol was approved by the Regional
Research Ethics Committee in Linköping in 2009
(Dnr. 111-09). Before submission to the committee the
protocol was reviewed with regard to ethical issues
related to the participants, particularly considering
non-malfeasance, autonomy, and fidelity [30]. Prior to
invitation and randomization, clients displaying signs of
severe psychiatric disease are referred to psychiatric spe-
cialists. The research will contribute to the development
o ft h ee v i d e n c eb a s ei nt h ea r e a ,w i t hp o t e n t i a lf u t u r e
benefits for participants and society. All participation
will be based on informed consent. The clients will be
able to withdraw from the study at any time, while still
being supplied routine CBT services. The integrity of
the randomization procedure will be checked on a regu-
lar basis.
Discussion
Health care services are increasingly moving out of the
physician’s office into IT-mediated treatment in the
community [18,31]. There is evidence that IT-supported
therapy works in controlled settings [20]. However, if
evidence is to be translated from stringent RCTs to
frontline clinical practice, some obstacles still remain
before IT-supported therapy can become routine prac-
tice. Two particular differences between evidence from
RCTs and frontline clinical settings that need to be
investigated are their applicability to total populations
and on clients with overt comorbidity. In addition, there
are a host of organizational and community context
issues that can only be investigated in real-world
settings.
Different applications of cell phone support for in situ
CBT have recently been reported [32]. The present pro-
tocol can be used to study the effectiveness of cell
phone-supported CBT for management of anxiety in dif-
ferent practice, organizational, and technical settings.
We recognize the lessons learned from early innovative
studies that had methodological shortcomings prevent-
ing them from transforming from evidence to practice
[21]. Although different types of software applications
for diagnosis and treatment of anxiety syndromes are
available off-the-shelf for stationary computers and the
Internet, the availability of high-quality applications for
portable computers and cell phones is scarce. To allow
the CBT-cell-phone strand to be replicated in other stu-
dies, the design of the application used in the case study
setting will be described in detail in forthcoming
reports.
Limitations
The study protocol complies with allocation conceal-
ment and completeness of follow-up data. However,
because of the tangible nature of cell-phone supported
therapy, blinding is not supported by the protocol. After
having been allocated a client and a treatment in a con-
cealed process, the therapist has total insight in the
therapy and, thereby, any use of supportive technologies
is not blinded.
Conclusions
This protocol for use in frontline clinical practice in
which effectiveness, adherence, and the role of the
therapists are analysed will provide evidence for what
are truly valuable cell-phone-supported CBT treatments
and guidance for the broader introduction of CBT in
health services.
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